BOOK
Physical Management for Neurological Conditions E-Book
Sheila Lennon | Gita Ramdharry | Geert Verheyden
(2018)
Additional Information
Book Details
Abstract
The second edition of the Neurological Physiotherapy Pocketbook is the only book for physiotherapists that provides essential evidence-based information in a unique and easy-to-use format, applicable to clinical settings.
Written by new international editors and contributors, this pocketbook provides quick and easy access to essential clinical information.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
IFC | ES1 | ||
Physical Management for Neurological Conditions | i | ||
Series Page | ii | ||
Physical Management for Neurological Conditions | iii | ||
Copyight | iv | ||
CONTENTS | v | ||
PREFACE | vii | ||
ACKNOWLEDGEMENTS | ix | ||
CONTRIBUTORS | xi | ||
1 - Background Knowledge | 1 | ||
1 - Guiding Principles in Neurological Rehabilitation | 3 | ||
WHY IS A CONCEPTUAL FRAMEWORK IMPORTANT? | 4 | ||
GUIDING PRINCIPLES FOR NEUROLOGICAL REHABILITATION | 5 | ||
Principle 1: The ICF | 5 | ||
The Value of Participation | 6 | ||
Principle 2: Team Work | 7 | ||
Principle 3: Person-Centred Care | 7 | ||
Principle 4: Prediction | 9 | ||
Principle 5: Neural Plasticity | 10 | ||
What Type of Training Drives Neural Plasticity and Recovery of Function? | 10 | ||
Principle 6: Motor Control: A Systems Model | 11 | ||
Principle 7: Functional Movement Reeducation | 11 | ||
Principle 8: Skill Acquisition | 12 | ||
Task Practice Issues | 12 | ||
Role of Feedback | 14 | ||
Amount of Practice | 14 | ||
The Optimal Theory of Motor Learning | 14 | ||
Principle 9: Self-Management (Self-Efficacy) | 15 | ||
Principle 10: Health Promotion | 15 | ||
CONCLUSION | 16 | ||
REFERENCES | 16 | ||
2 - Common Impairments and the Impact on Activity | 21 | ||
INTRODUCTION | 21 | ||
WEAKNESS | 22 | ||
Upper Motor Neurone Weakness | 22 | ||
Lower Motor Neurone Weakness | 22 | ||
FATIGUE | 23 | ||
General Fatigue | 23 | ||
Motor Fatigue | 23 | ||
DISORDERS OF MUSCLE TONE | 23 | ||
Hypertonus | 23 | ||
Hypotonus | 24 | ||
Dystonia | 25 | ||
Involuntary Muscle Spasms | 25 | ||
Dyskinesias | 25 | ||
Rigidity | 26 | ||
DISORDERS OF COORDINATION | 26 | ||
Cerebellar Ataxia | 26 | ||
Sensory Ataxia | 26 | ||
Resting Tremor | 26 | ||
Intention Tremor | 27 | ||
Loss of Dexterity | 27 | ||
DISORDERS OF MOTOR PLANNING | 28 | ||
Apraxia | 28 | ||
Bradykinesia/Akinesia | 28 | ||
Freezing of Gait | 28 | ||
VESTIBULAR DISORDERS | 28 | ||
Peripheral Vestibular Disorders | 28 | ||
Central Vestibular Disorders | 29 | ||
Unilateral Spatial Neglect | 29 | ||
Contraversive Pushing | 29 | ||
Paraesthesia and Dysaesthesia | 30 | ||
Pain | 30 | ||
SECONDARY COMPLICATIONS | 30 | ||
Contracture | 30 | ||
Physical Inactivity and Deconditioning | 31 | ||
Learned Non-Use | 31 | ||
CONCLUSION | 32 | ||
REFERENCES | 32 | ||
3 - Observation and Analysis of Movement | 37 | ||
WALKING | 37 | ||
The Gait Cycle | 38 | ||
Walking Kinematics and Muscle Activity | 38 | ||
Walking Kinetics | 42 | ||
Spatiotemporal Characteristics | 43 | ||
Clinical Focus: Walking for People with Parkinson’s | 43 | ||
SIT TO STAND | 43 | ||
Typical Phases of Sit to Stand | 44 | ||
Muscle Action During Sit to Stand | 44 | ||
Contextual Factors Influencing Sit to Stand | 44 | ||
Clinical Focus on Sit to Stand for People Following Stroke | 45 | ||
ROLLING AND GETTING OUT OF BED | 45 | ||
Clinical Focus on Getting Out of Bed for People with Parkinson’s | 47 | ||
REACH AND GRASP | 51 | ||
Essential Components of Reach and Grasp | 51 | ||
Kinematics | 53 | ||
Muscle Activity | 53 | ||
Clinical Focus on Reach and Grasp for People with Stroke | 55 | ||
POSTURE AND BALANCE | 55 | ||
Sensorimotor Control of Balance | 57 | ||
Movement Analysis Strategies to Quantify Posture | 59 | ||
Movement Analysis Strategies to Quantify Balance | 60 | ||
Clinical Foci of Posture and Balance (Ataxia, Parkinson’s and Hemiplegic Stroke) | 61 | ||
KEY MESSAGES | 65 | ||
REFERENCES | 66 | ||
4 - Measurement Tools | 77 | ||
INTRODUCTION | 77 | ||
Impairments (Problems in Body Functions or Structures) | 78 | ||
Activity Limitations | 79 | ||
TYPES OF MEASUREMENT TOOLS | 79 | ||
PSYCHOMETRIC PROPERTIES | 82 | ||
Reliability | 82 | ||
Assessing Reliability for Nominal and Ordinal Data with Two Scoring Categories | 83 | ||
Assessing Reliability for Ordinal Data with Three or More Categories | 83 | ||
Assessing Reliability for Interval and Ratio Data | 84 | ||
Validity | 85 | ||
Content Validity | 85 | ||
Construct Validity | 85 | ||
Criterion-Related Validity | 86 | ||
Responsiveness | 87 | ||
APPLIED MEASUREMENT SCIENCE: TOWARDS CLINICAL IMPLEMENTATION | 88 | ||
CONCLUSIONS | 88 | ||
REFERENCES | 89 | ||
5 - Goal Setting in Rehabilitation | 91 | ||
INTRODUCTION | 91 | ||
DEFINITIONS AND ASSUMPTIONS | 92 | ||
Rehabilitation Goals and Goal Setting | 92 | ||
Activities to Enhance Goal Pursuit | 92 | ||
PRAGMATIC PERSON-CENTRED GOAL SETTING | 93 | ||
Family Involvement in Goal Setting | 94 | ||
Should Goals Be Measurable? | 95 | ||
GOAL SETTING IN STROKE REHABILITATION – ADDRESSING THE CHANGING NEEDS FROM ACUTE CARE TO COMMUNITY LIFE | 96 | ||
Acute Rehabilitation | 96 | ||
Postacute Inpatient Rehabilitation | 98 | ||
Postacute Community-Based Rehabilitation | 99 | ||
Long-Term Recovery Following Stroke | 101 | ||
GOAL ACHIEVEMENT AS AN OUTCOME MEASURE – CHALLENGING CURRENT ASSUMPTIONS | 102 | ||
The Appeal of Goal Attainment as an Outcome | 102 | ||
An Overview of Goal Attainment Scaling | 103 | ||
Problems with Goal Attainment as an Outcome | 103 | ||
CONCLUSION | 105 | ||
REFERENCES | 106 | ||
6 - Respiratory Management | 111 | ||
INTRODUCTION | 111 | ||
CENTRAL NERVOUS CONTROL OF BREATHING | 112 | ||
RESPIRATORY ASSESSMENT OF THE NEUROLOGICAL PATIENT | 112 | ||
Lung Function | 113 | ||
Peak Cough Flow | 113 | ||
Arterial Blood Gases | 114 | ||
Chest Radiographs | 115 | ||
Respiratory Pattern | 115 | ||
Respiratory Reserve (PaO2/FiO2 Ratio) | 115 | ||
EARLY MOBILISATION | 116 | ||
RESPIRATORY TREATMENT AND MANAGEMENT | 116 | ||
Maximal Insufflation Capacity | 116 | ||
Manual Cough | 118 | ||
Mechanical Insufflation and Exsufflation | 118 | ||
Other Considerations | 119 | ||
Respiratory Muscle Training | 119 | ||
Management of Acute Respiratory Failure | 120 | ||
Tracheostomy and Weaning | 120 | ||
RESPIRATORY FUNCTION IN NEUROLOGICAL CONDITIONS | 120 | ||
Central Conditions | 120 | ||
Subarachnoid Haemorrhage | 120 | ||
Spinal Cord Injury and Disease | 121 | ||
Anterior Horn Cell Conditions | 121 | ||
Neuropathy | 122 | ||
Neuromuscular Junction | 122 | ||
Muscle Conditions | 122 | ||
MANAGEMENT OF TRAUMATIC BRAIN INJURY | 123 | ||
CONCLUSION | 126 | ||
REFERENCES | 127 | ||
2- Management of Specific Conditions | 129 | ||
7 - Stroke | 131 | ||
INTRODUCTION | 131 | ||
EPIDEMIOLOGY | 132 | ||
PATHOPHYSIOLOGY | 132 | ||
DIAGNOSIS | 132 | ||
MEDICAL MANAGEMENT | 133 | ||
SETTING | 133 | ||
INTERDISCIPLINARY TEAM | 133 | ||
CLINICAL PRESENTATION | 134 | ||
ASSESSMENT | 134 | ||
Hyperacute Phase | 136 | ||
Rehabilitation Phase | 136 | ||
Chronic Phase | 137 | ||
Prognosis and Time Course of Recovery | 138 | ||
INTERVENTIONS | 139 | ||
General Therapy Principles | 140 | ||
Lower Limb and Locomotor Recovery | 141 | ||
Gait Training | 142 | ||
Overground Walking | 142 | ||
Speed-Dependent Treadmill Training | 142 | ||
Body Weight Supported Treadmill Training | 143 | ||
Robot-Assisted Gait Training | 143 | ||
Circuit Class Training | 143 | ||
Electrostimulation of the Paretic Lower Limb | 144 | ||
Upper Limb Recovery | 144 | ||
Constraint-Induced Movement Therapy | 144 | ||
Bilateral Arm Training (With Rhythmic Auditory Cueing) | 144 | ||
Virtual Reality, Including Interactive Video Gaming | 145 | ||
Electrostimulation of the Paretic Arm and Hand | 145 | ||
Robot-Assisted Therapy for the Upper Limb | 145 | ||
Therapy Delivery | 146 | ||
CONCLUSIONS | 146 | ||
CASE STUDY | 146 | ||
REFERENCES | 149 | ||
8 - Traumatic Brain Injury | 153 | ||
INTRODUCTION | 153 | ||
EPIDEMIOLOGY | 154 | ||
PATHOPHYSIOLOGY | 154 | ||
Primary Brain Injury | 154 | ||
Secondary Brain Injury | 155 | ||
Associated Injuries | 155 | ||
DIAGNOSIS | 155 | ||
Coma | 156 | ||
Posttraumatic Amnesia | 156 | ||
MEDICAL MANAGEMENT | 156 | ||
Intracranial Pressure | 157 | ||
Multidisciplinary Care | 157 | ||
CLINICAL PRESENTATION | 158 | ||
ASSESSMENT | 158 | ||
Abnormal Tone | 159 | ||
Muscle Paresis | 159 | ||
Disorders of Movement | 159 | ||
Balance and Vestibular Function | 159 | ||
Muscle and Joint Range of Motion | 160 | ||
Concurrent Musculoskeletal Injuries | 160 | ||
Pain | 160 | ||
Function | 160 | ||
Summary | 161 | ||
PROGNOSIS/TIME COURSE | 161 | ||
INTERVENTIONS | 162 | ||
Hypertonicity and Spasticity | 162 | ||
Muscle Paresis | 162 | ||
Disorders of Movement | 162 | ||
Balance and Vestibular Function | 163 | ||
Muscle and Joint Range of Motion | 163 | ||
Concurrent Musculoskeletal Injuries | 163 | ||
Pain | 164 | ||
Function | 164 | ||
OTHER CONSIDERATIONS | 164 | ||
CONCLUSION | 164 | ||
CASE STUDY | 165 | ||
REFERENCES | 168 | ||
9 - Spinal Cord Injury | 171 | ||
INTRODUCTION | 171 | ||
EPIDEMIOLOGY | 172 | ||
Incidence Data | 172 | ||
AETIOLOGY | 172 | ||
PATHOPHYSIOLOGY | 173 | ||
DIAGNOSIS | 173 | ||
PROGNOSIS | 176 | ||
INCOMPLETE SYNDROMES | 176 | ||
EARLY ACUTE MANAGEMENT | 176 | ||
Breaking the News | 179 | ||
Physical Management | 179 | ||
Facilitation of Range, Length and Movement | 180 | ||
Mobilisation | 182 | ||
RESPIRATORY ASSESSMENT | 182 | ||
RESPIRATORY TREATMENT | 184 | ||
Weaning From Ventilatory Support (RISCI 2017) | 184 | ||
Long-Term Respiratory Management | 185 | ||
CLINICAL PRESENTATION | 185 | ||
Spinal Shock | 185 | ||
Autonomic Dysfunction | 185 | ||
Cardiovascular | 185 | ||
Thermoregulation | 186 | ||
Autonomic Dysreflexia | 186 | ||
Bladder, Bowels and Sexual Dysfunction | 186 | ||
Weakness | 186 | ||
Sensory Changes | 187 | ||
Balance | 187 | ||
Pain | 187 | ||
Spasticity | 187 | ||
ASSESSMENT | 187 | ||
PHYSICAL MANAGEMENT | 187 | ||
Strength Training | 189 | ||
Aquatic Therapy | 189 | ||
Facilitation of Movement | 189 | ||
Splinting | 190 | ||
Seating | 190 | ||
Functional Mobility | 191 | ||
Standing | 191 | ||
Gait Training | 192 | ||
Cardiovascular Fitness | 193 | ||
Other Modalities | 194 | ||
Loss of Range of Movement and Postural Deformity | 194 | ||
Shoulder Pain | 194 | ||
Tissue Viability | 195 | ||
Heterotropic Ossification | 195 | ||
Syrinx and Syringomyelia | 195 | ||
PAEDIATRIC CONSIDERATIONS | 195 | ||
DISCHARGE PLANNING AND LIFELONG CARE | 196 | ||
CONCLUSION | 196 | ||
CASE STUDY | 196 | ||
Progress With Rehabilitation | 196 | ||
ACKNOWLEDGEMENT | 200 | ||
REFERENCES | 200 | ||
10 - Multiple Sclerosis | 205 | ||
INTRODUCTION | 205 | ||
EPIDEMIOLOGY | 205 | ||
PATHOPHYSIOLOGY | 206 | ||
DIAGNOSIS | 206 | ||
CLASSIFICATION | 207 | ||
MEDICAL MANAGEMENT | 208 | ||
Disease-Modifying Therapies | 208 | ||
Lifestyle Modifications and Comorbidities | 209 | ||
PROGNOSIS | 209 | ||
CLINICAL PRESENTATION | 209 | ||
ASSESSMENT | 210 | ||
MANAGEMENT | 212 | ||
Health Promotion | 212 | ||
Restorative Rehabilitation | 213 | ||
Maintenance Rehabilitation | 213 | ||
INTERVENTIONS | 213 | ||
Impaired Mobility, Balance and Falls | 213 | ||
Sedentary Behaviour, Weakness and Deconditioning | 215 | ||
Upper Limb Impairment | 216 | ||
Ataxia | 216 | ||
Spasticity | 216 | ||
Fatigue | 218 | ||
Pain | 218 | ||
Respiratory Dysfunction | 218 | ||
Bladder and Bowel | 219 | ||
Cognitive Impairment | 219 | ||
Anxiety and Depression | 219 | ||
Pressure Ulcers | 220 | ||
CONCLUSION | 220 | ||
Key Assessment Findings | 221 | ||
Treatment Plan | 221 | ||
Initial Outpatient Physiotherapy Session | 221 | ||
Progress Review at 3 Months | 222 | ||
REFERENCES | 223 | ||
11 - Parkinson’s | 227 | ||
INTRODUCTION | 227 | ||
EPIDEMIOLOGY AND AETIOLOGY | 228 | ||
NEUROANATOMY AND PATHOPHYSIOLOGY | 229 | ||
Pharmacological Management | 232 | ||
Surgical Management | 232 | ||
TEAM MANAGEMENT | 233 | ||
Time Course From Diagnosis of Parkinson’s and Communication | 235 | ||
PHYSIOTHERAPY MANAGEMENT | 236 | ||
Framework for Physiotherapy Intervention | 237 | ||
Referral to Physiotherapy | 237 | ||
Physiotherapy History Taking | 238 | ||
Physical Assessment | 238 | ||
Goal Setting and Choosing Treatments | 241 | ||
Exercise | 241 | ||
Practice | 243 | ||
Movement Strategies Training | 244 | ||
CONCLUSION | 244 | ||
CASE STUDY: MAIN ISSUE OF SIT-TO-STAND TASK | 246 | ||
Quick Reference Card 1: History Taking | 246 | ||
Quick Reference Card 2: Physical Examination | 247 | ||
Quick Reference Card 3: Treatment Goal and Quick Reference Card 4: GRADE-Based Recommendations | 247 | ||
REFERENCES | 248 | ||
12 - Inherited Neurological Conditions | 253 | ||
INTRODUCTION | 254 | ||
HUNTINGTON’S DISEASE | 254 | ||
Epidemiology | 254 | ||
Genetics | 254 | ||
Anatomy and Pathophysiology | 255 | ||
Clinical Presentation | 255 | ||
Medical Management | 256 | ||
A Standard of Care for Huntington’s Disease | 257 | ||
Physiotherapy Assessment and Prognosis | 257 | ||
Time Course and Corresponding Physiotherapy Management | 260 | ||
Treatment Selection and Secondary Complications/Special Problems | 260 | ||
HEREDITARY ATAXIAS | 264 | ||
Epidemiology and Genetics | 264 | ||
Autosomal Dominant Cerebellar Ataxias | 264 | ||
Autosomal Recessive Ataxias | 264 | ||
Friedreich’s Ataxia | 266 | ||
Diagnosis and Genetic Testing | 266 | ||
Spasticity and Dystonia | 266 | ||
Scoliosis and Orthotic Management | 266 | ||
Cardiac Symptoms | 266 | ||
Pharmacological and Surgical Management of Ataxia | 267 | ||
Coenzyme Q and Idebenone in Friedreich’s Ataxia | 267 | ||
Physiotherapy Assessment | 267 | ||
Disease-Specific Scales | 268 | ||
Time Course and Corresponding Management | 268 | ||
Balance, Walking and Mobility | 269 | ||
Anatomy, Pathophysiology and Clinical Presentation | 271 | ||
Diagnosis | 271 | ||
Physiotherapy Assessment | 272 | ||
Disease-Specific Scales | 272 | ||
Time Course and Corresponding Management | 272 | ||
Treatment Selection, Secondary Complications and Special Problems | 273 | ||
SUMMARY | 273 | ||
Classification | 275 | ||
Examination | 276 | ||
History | 276 | ||
Body Structures and Function | 276 | ||
Activities | 277 | ||
Prognosis | 277 | ||
Intervention | 277 | ||
Outcomes (8 months) | 277 | ||
ACKNOWLEDGEMENTS | 278 | ||
REFERENCES | 278 | ||
13 - Motor Neurone Disease | 285 | ||
INTRODUCTION | 285 | ||
EPIDEMIOLOGY | 285 | ||
ANATOMY AND PATHOPHYSIOLOGY | 286 | ||
GENETIC FACTORS | 286 | ||
GEOGRAPHICAL AND ENVIRONMENTAL FACTORS | 286 | ||
CLINICAL PHENOTYPES | 287 | ||
DIAGNOSIS | 287 | ||
(EARLY) MEDICAL MANAGEMENT | 289 | ||
SIGNS, SYMPTOMS AND CLINICAL PRESENTATION | 289 | ||
ASSESSMENT AND PROGNOSIS | 290 | ||
Disease-Specific Measures | 292 | ||
Prognosis | 293 | ||
TIME COURSE AND CORRESPONDING MANAGEMENT | 293 | ||
TREATMENT SELECTION AND SECONDARY COMPLICATIONS AND SPECIAL PROBLEMS | 294 | ||
Assistive Devices and Orthoses | 296 | ||
Exercise in Motor Neurone Disease | 296 | ||
Overwork Damage Versus Disuse Atrophy | 296 | ||
Types of Exercise | 297 | ||
Evolving Wheelchair Needs | 298 | ||
Respiratory Issues | 299 | ||
CONCLUSION | 302 | ||
CASE STUDY | 302 | ||
REFERENCES | 305 | ||
14 - Polyneuropathies | 309 | ||
INTRODUCTION | 309 | ||
ANATOMY AND PHYSIOLOGY | 310 | ||
CAUSES OF NEUROPATHY | 310 | ||
SPECIFIC TYPES OF NEUROPATHY | 311 | ||
Acquired Neuropathies | 311 | ||
Guillain–Barré Syndrome | 312 | ||
Chronic Demyelinating Polyradiculoneuropathy | 314 | ||
Diabetic Neuropathy | 315 | ||
ASSESSMENT OF PEOPLE WITH POLYNEUROPATHIES | 318 | ||
PHYSICAL MANAGEMENT AND REHABILITATION APPROACHES FOR PEOPLE WITH POLYNEUROPATHIES | 319 | ||
Acute Rehabilitation of Acquired Polyneuropathies | 320 | ||
Long-Term Physical Management and Rehabilitation | 321 | ||
Self-Management | 321 | ||
Exercise and Physical Activity Interventions in Polyneuropathy | 321 | ||
Balance Interventions | 322 | ||
Orthotic Management | 322 | ||
Pain and Fatigue Management | 323 | ||
CASE STUDY | 323 | ||
Presenting Impairments | 323 | ||
Muscle Strength and Sensation | 324 | ||
Gait | 324 | ||
Balance | 324 | ||
Pain | 325 | ||
Physiotherapy Options for Mr V | 325 | ||
Orthotic Prescription | 325 | ||
Range of Movement | 325 | ||
Muscle Strength and Aerobic Exercise | 325 | ||
Balance | 325 | ||
Outcome | 325 | ||
Management of Upper Limb Function | 326 | ||
Orthotics and Equipment | 326 | ||
Stretches | 326 | ||
3 - Specific Aspects ofManagement | 377 | ||
17 - Self-Management | 379 | ||
INTRODUCTION | 379 | ||
SELF-MANAGEMENT: WHAT IS IT AND WHY NOW? | 380 | ||
Defining Self-Management | 381 | ||
Self-Management Is Not New | 383 | ||
SELF-MANAGEMENT PROGRAMMES: THEORY AND RESEARCH | 383 | ||
Understanding Responses to Neurological Disability | 383 | ||
Social Cognitive Theory and Self-Efficacy – a Critical Factor in Self-Management | 384 | ||
Stress Coping Model | 385 | ||
Transtheoretical Model of Behaviour Change and Motivational Interviewing | 385 | ||
Components of Self-Management Programmes | 386 | ||
SELF-MANAGEMENT PROGRAMMES: THE EVIDENCE BASE FOR NEUROLOGICAL CONDITIONS | 387 | ||
Adapting the Self-Management Approach to Neurological Conditions | 387 | ||
Issues in Self-Management Research | 388 | ||
Self-Management and Stroke | 389 | ||
Measurement of Self-Management | 390 | ||
SUPPORTING SELF-MANAGEMENT: PROVIDING INFORMATION ALONE IS NOT ENOUGH | 391 | ||
CONCLUSION | 392 | ||
REFERENCES | 394 | ||
18 - Virtual Rehabilitation: Virtual Reality and Interactive Gaming Technologies in Neurorehabilitation | 397 | ||
INTRODUCTION | 397 | ||
ROLE OF VIRTUAL REALITY TECHNOLOGIES IN NEUROLOGICAL REHABILITATION | 398 | ||
VIRTUAL REALITY TECHNOLOGIES WITH POTENTIAL FOR USE IN THE REHABILITATION SETTING | 399 | ||
Nintendo Wii and Nintendo Wii Fit | 400 | ||
Microsoft Xbox with Kinect Sensor | 401 | ||
PlayStation2 EyeToy, PlayStation3 Eye and PlayStation MOVE | 402 | ||
Head-Mounted Displays | 402 | ||
Smartphones, Tablets and Apps | 403 | ||
Customised Software for Rehabilitation | 403 | ||
Current Evidence | 404 | ||
PRACTICAL TIPS FOR CHOOSING VIRTUAL REALITY TECHNOLOGIES | 405 | ||
Choosing Technology | 405 | ||
Choosing a Virtual Reality Task/Game | 406 | ||
Client Considerations | 406 | ||
Resources for Clinicians | 407 | ||
CONCLUSION | 407 | ||
CASE HISTORY | 407 | ||
REFERENCES | 408 | ||
19 - Falls and Their Management | 411 | ||
INTRODUCTION | 411 | ||
FALLS AND FALLING | 411 | ||
Extent of the Problem | 413 | ||
Causes of Falling | 413 | ||
Consequences of Falling | 414 | ||
ASSESSING PEOPLE WHO HAVE FALLEN | 414 | ||
Interviewing Patients and Carers | 416 | ||
Falls Diaries | 416 | ||
Observing Fall-Related Activities | 417 | ||
Video | 418 | ||
Standard Tests and Outcome Measures | 418 | ||
PREVENTING FALLS AND MANAGING PEOPLE WHO HAVE FALLEN | 419 | ||
The Person at Risk for Falling | 419 | ||
Exercise and Other Training Programmes | 419 | ||
Continued Physical Activity | 421 | ||
Movement Strategies | 422 | ||
External Environment | 424 | ||
Engagement With Fall Prevention | 424 | ||
Not Every Fall is Preventable | 425 | ||
EFFECTIVE FALLS SERVICES AND TEAMS | 425 | ||
Service Models | 425 | ||
A Multifactorial Approach | 425 | ||
CONCLUSION | 425 | ||
REFERENCES | 426 | ||
20 - Physical Activity and Exercise in Neurological Rehabilitation | 433 | ||
NEUROLOGICAL CONDITIONS | 433 | ||
PHYSICAL ACTIVITY | 434 | ||
Exercise | 435 | ||
Fitness | 435 | ||
Physical Activity, Exercise and Fitness in Long-Term Neurological Conditions | 435 | ||
Considerations for Prescribing Neurological Conditions | 436 | ||
Stage/Severity of Disease | 436 | ||
Condition Progression | 436 | ||
Neurological Symptoms | 436 | ||
Likelihood of Secondary Conditions | 436 | ||
Exercise Response/Recovery | 436 | ||
ASSESSMENT AND MONITORING OF EXERCISE | 437 | ||
Safety | 437 | ||
International Classification of Function Model and Exercise, Physical Activity and Fitness | 437 | ||
Assessment of Key Body Functioning Fitness Components | 437 | ||
Assessment and Monitoring of Health | 438 | ||
Monitoring Symptoms | 438 | ||
Monitoring Participation, Health and Well-being | 438 | ||
Monitoring Exercise and Physical Activity Levels | 438 | ||
Wider Assessment | 439 | ||
Exercise Prescription | 439 | ||
Exercise Prescription Setting | 439 | ||
Exercise Prescription Content | 439 | ||
Limit to Capacity | 439 | ||
Exercise Response and Recovery | 439 | ||
Frequency | 439 | ||
Intensity | 439 | ||
Timing | 440 | ||
Type | 440 | ||
Reducing Sedentary Time | 440 | ||
Barriers and Facilitators | 440 | ||
Changing Behaviour | 440 | ||
Conclusion | 441 | ||
Summary of Exercise Prescription Guidance | 442 | ||
REFERENCES | 442 | ||
21 - Vestibular Rehabilitation | 445 | ||
INTRODUCTION | 445 | ||
EPIDEMIOLOGY | 446 | ||
ANATOMY AND PHYSIOLOGY OF THE VESTIBULAR SYSTEM | 446 | ||
VESTIBULAR OCULAR REFLEX AND VESTIBULOSPINAL REFLEX | 449 | ||
PATHOPHYSIOLOGY | 449 | ||
PERIPHERAL DISORDERS | 449 | ||
CENTRAL DISORDERS | 451 | ||
Vestibular Migraine | 451 | ||
PERSISTENT POSTURAL PERCEPTUAL DIZZINESS | 451 | ||
DIAGNOSIS | 452 | ||
MEDICAL AND SURGICAL MANAGEMENT | 452 | ||
Ménière’s Disease | 454 | ||
Persistent Benign Paroxysmal Positional Vertigo | 454 | ||
Acoustic Neuromas | 454 | ||
ASSESSMENT | 455 | ||
Physical Impairments | 455 | ||
Functional Ability | 455 | ||
Outcome Measures | 456 | ||
PROGNOSIS | 457 | ||
INTERVENTIONS | 460 | ||
Vestibular Paresis/Hypofunction | 460 | ||
Balance and Gait Reeducation | 462 | ||
Management of Benign Paroxysmal Positional Vertigo | 464 | ||
Secondary Problems | 464 | ||
OTHER CONSIDERATIONS | 464 | ||
Multidisciplinary Team | 464 | ||
Specialist Centres and Support Groups | 464 | ||
Support Groups | 466 | ||
CONCLUSION | 466 | ||
CASE STUDIES | 466 | ||
Case 1: Peripheral Vestibular Neuritis | 466 | ||
Case 2: Benign Paroxysmal Positional Vertigo | 467 | ||
REFERENCES | 467 | ||
22 - Pain Management | 473 | ||
INTRODUCTION | 474 | ||
Contemporary Views on Pain | 474 | ||
Patient Experience of Pain | 474 | ||
Types of Pain | 474 | ||
Epidemiology of Pain Associated with Neurological Conditions | 475 | ||
ANATOMY AND PATHOPHYSIOLOGY OF PAIN | 475 | ||
SIGNS AND SYMPTOMS AND CLINICAL PRESENTATION | 477 | ||
Musculoskeletal Pain | 477 | ||
Neuropathic Pain | 478 | ||
Peripheral Neuropathic Pain | 478 | ||
Central Neuropathic Pain | 478 | ||
Progressive Neurological Conditions | 478 | ||
Multiple Sclerosis | 478 | ||
Parkinson’s | 479 | ||
Huntington’s Disease | 479 | ||
Amyotrophic Lateral Sclerosis: Motor Neurone Disease | 479 | ||
Other Neurological Diseases | 479 | ||
Central Nervous System Damage | 479 | ||
Stroke | 479 | ||
Traumatic Brain Injuries | 480 | ||
Spinal Cord Injuries | 480 | ||
DIAGNOSIS, ASSESSMENT AND PROGNOSIS | 481 | ||
Subjective Assessment | 481 | ||
Red and Yellow Flags | 482 | ||
Factors that Influence the Reliability of Subjective Pain Report | 482 | ||
Objective Assessment | 482 | ||
PRINCIPLES OF PAIN MANAGEMENT | 482 | ||
Pharmacological Management of Pain | 483 | ||
Surgical Management of Pain | 485 | ||
Electrophysical Techniques | 485 | ||
Manual Therapy | 485 | ||
Physical Activity and Exercise | 486 | ||
Splinting, Casting and Bracing | 486 | ||
Invasive Electrical Stimulation Techniques | 486 | ||
Noninvasive Electrical Brain Stimulation Techniques | 487 | ||
Transcutaneous Electrical Nerve Stimulation | 487 | ||
Acupuncture | 487 | ||
Therapeutic Ultrasound | 487 | ||
Thermal Therapies | 488 | ||
Low-Level Laser Therapy | 488 | ||
Visual Feedback, Motor Imagery and Body Illusions | 488 | ||
Psychological Approaches | 488 | ||
Self-Management | 489 | ||
Setting Treatment Goals | 490 | ||
Evaluating Response to Treatment | 490 | ||
Strategies to Improve Treatment Effect | 490 | ||
CONCLUSIONS | 491 | ||
CASE STUDIES | 491 | ||
Case 1: Diabetic Neuropathic Pain | 491 | ||
Case 2: Phantom Limb Pain | 492 | ||
REFERENCES | 493 | ||
23 - Clinical Neuropsychology in Rehabilitation | 499 | ||
INTRODUCTION | 499 | ||
NEUROPSYCHOLOGICAL ASSESSMENT | 500 | ||
Cognitive Functions | 500 | ||
Assessment of Emotional and Behavioural Adjustment | 501 | ||
Affective and Mediating Factors | 501 | ||
Assessment of Outcomes and Quality of Life | 502 | ||
NEUROPSYCHOLOGICAL INTERVENTIONS | 502 | ||
Cognitive Interventions | 503 | ||
Behavioural Interventions | 503 | ||
Psychotherapy: Staff, Team and Organisational Support and Research | 504 | ||
NEUROPSYCHOLOGICAL CONSEQUENCES OF NEUROLOGICAL DISORDERS | 504 | ||
Age of Acquisition and Neuroplasticity | 504 | ||
Focal Versus Diffuse | 504 | ||
Acute Versus Chronic | 504 | ||
Progressive Versus Static | 505 | ||
Site and Lateralisation | 505 | ||
Traumatic Brain Injury | 505 | ||
Stroke | 505 | ||
Hypoxic Brain Injury | 505 | ||
Degenerative Conditions | 506 | ||
Spinal Injuries | 506 | ||
Neuropsychological Disorders of Movement | 506 | ||
Apraxia | 509 | ||
Neglect | 509 | ||
Functional Disorders | 509 | ||
PROCESS OF REHABILITATION | 510 | ||
CONCLUSIONS | 510 | ||
Psychological Adjustment | 510 | ||
ACKNOWLEDGEMENTS | 510 | ||
REFERENCES | 511 | ||
24 - Complex Case Management | 513 | ||
INTRODUCTION | 513 | ||
MUSCULOSKELETAL INTEGRATION IN NEUROLOGICAL UPPER LIMB APPROACH -MOVEMENT AND MUSCLE ACTIVATION OF THE SHOULDER COMPLEX AFTER STROKE: A MUSCULOSKELETAL VIEW ON POSTSTROKE SHOULDER ASSESSMENT AND REHABILITATION | 514 | ||
Evaluation of the Shoulder Complex from a Musculoskeletal Viewpoint | 514 | ||
Musculoskeletal Management of Shoulder Complex Dysfunctions After Stroke | 520 | ||
Illustration by Means of a Case Presentation | 521 | ||
Summary | 522 | ||
SPASTICITY: WHEN AND HOW TO TREAT THE CLINICAL PROBLEM IN NEUROLOGICAL REHABILITATION | 522 | ||
Upper Motor Neurone Syndrome | 523 | ||
Spasticity | 523 | ||
Principles of Management | 524 | ||
Physical and Pharmacological Treatment | 524 | ||
Evaluation of Outcome | 526 | ||
Summary | 528 | ||
ON THE ROAD WITH MULTIPLE SCLEROSIS - CHALLENGES IN SCREENING, ASSESSMENT AND TRAINING OF DRIVING | 528 | ||
Driving as an Important Instrumental Activity ofDaily Living | 528 | ||
Aspects of the Driving Evaluation Process | 529 | ||
Case Presentation | 531 | ||
REFERENCES | 534 | ||
Answers to Self-Assessment Questions | 539 | ||
CHAPTER 1 | 539 | ||
CHAPTER 2 | 540 | ||
Sit to Stand | 540 | ||
Rolling and Getting Out of Bed | 540 | ||
Reach and Grasp | 540 | ||
Posture and Balance | 541 | ||
CHAPTER 4 | 541 | ||
CHAPTER 5 | 542 | ||
CHAPTER 6 | 543 | ||
CHAPTER 7 | 543 | ||
CHAPTER 8 | 543 | ||
CHAPTER 9 | 544 | ||
CHAPTER 10 | 544 | ||
CHAPTER 11 | 545 | ||
Hereditary Ataxia | 546 | ||
HSP (Henoch-Schonlein Purpura) | 546 | ||
CHAPTER 13 | 547 | ||
CHAPTER 14 | 547 | ||
CHAPTER 15 | 547 | ||
CHAPTER 16 | 548 | ||
CHAPTER 17 | 548 | ||
CHAPTER 18 | 549 | ||
CHAPTER 19 | 550 | ||
CHAPTER 20 | 550 | ||
CHAPTER 21 | 551 | ||
CHAPTER 22 | 551 | ||
CHAPTER 23 | 552 | ||
CHAPTER 24 | 552 | ||
Abbreviations | 555 | ||
INDEX | 559 | ||
A | 559 | ||
B | 560 | ||
C | 561 | ||
D | 562 | ||
E | 562 | ||
F | 563 | ||
G | 564 | ||
H | 564 | ||
I | 565 | ||
J | 566 | ||
K | 566 | ||
L | 566 | ||
M | 566 | ||
N | 568 | ||
O | 569 | ||
P | 569 | ||
Q | 571 | ||
R | 571 | ||
S | 572 | ||
T | 575 | ||
U | 576 | ||
V | 576 | ||
W | 576 | ||
IBC | ES2 |